| 名稱 | EGFR H773_V774insPHPH/BaF3 |
| 型號(hào) | CBP73223 |
| 報(bào)價(jià) | ![]() |
| 特點(diǎn) | EGFR H773_V774insPHPH/BaF3,母細(xì)胞:BaF3,凍存條件:90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- PTPRZ1-MET腦膠質(zhì)瘤分子診斷標(biāo)準(zhǔn)品上新
- STEAP1/2的細(xì)胞模型
- CSF3R細(xì)胞篩選模型
- 羅氏免疫療法獲FDA批準(zhǔn)治療晚期非小細(xì)胞肺癌(NSCLC)
- RET基因如何檢測(cè)?
- 從“腫瘤免疫療法”發(fā)展,看“單抗、CAR-T”任重而道遠(yuǎn)!
- 耐藥ATCC細(xì)胞株如何構(gòu)建看完就會(huì)知道
- 上海生科院發(fā)現(xiàn)PKM2抑制細(xì)胞凋亡的新機(jī)制
- Science:腫瘤非整倍體與癌癥免疫療法反應(yīng)下降相關(guān)聯(lián)
- 肥胖與腫瘤治療新星靶點(diǎn)——GDF15-GFRAL
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73223EGFR H773_V774insPHPH/BaF3
- 詳細(xì)內(nèi)容
| CBP73223 | |
| I. Introduction | |
Cell Line Name: | EGFR H773_V774insPHPH/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling. |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
EGFR (HER1), epidermal growth factor receptor, is a tyrosine kinase receptor, which activates RAS/RAF/MEK and PI3K/AKT/mTOR pathways, leading to increased cell proliferation and growth (PMID: 24312144). EGFR activating mutations, amplification, and overexpression are found in a variety of tumors, including non-small cell lung cancer (PMID: 26609494, PMID: 30284706) and colorectal cancer (PMID: 30243897), and the EGFRvIII variant is commonly found in glioblastoma (PMID: 30201736). | |
| III. Representative Data | |
1. WB of EGFR H773_V774insPHPH/BaF3
| |
2. Anti-proliferation assay | |





會(huì)員_a.png)